Transforming Growth Factor Beta
Transforming Growth Factor Beta - Related Videos
02:25
An Assay for Analyzing Test β-Glucan as an Immunotherapy Strategy against Brain Cancer Cells
0 Views •
2025
This video demonstrates an in vitro assay utilizing β-glucans to activate microglial cells for the production of superoxide radicals, a reactive oxygen species. In brain cancer cells, the generated reactive oxidants actively suppress tumor cell proliferation and induce cell death.
07:49
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
0 Views •
Cited by 7 •
2018
A protocol for in vitro induction of endothelial-mesenchymal transition (EndMT), which is useful for investigating cellular signaling pathways involved in EndMT, is described. In this experimental model, EndMT is induced by treatment with TGF-β in MS-1 endothelial cells.
18:27
Preparing T Cell Growth Factor from Rat Splenocytes
0 Views •
Cited by 12 •
2007
We describe the preparation of T cell growth factor used for the in vitro expansion of antigen-specific rat T lymphocyte lines.
07:56
Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
0 Views •
Cited by 14 •
2012
We have modified the conventional yeast two-hybrid screening, an effective genetic tool in identifying protein interaction. This modification markedly shortens the process, reduces the workload, and most importantly, reduces the number of false positives. In addition, this approach is reproducible and reliable.
09:04
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
0 Views •
Cited by 7 •
2016
We describe a simple cell-based bioassay for detecting, quantifying and monitoring the activity of members of the vascular endothelial growth factor family of ligands. The assay uses chimeric receptors expressed in a factor-dependent cell line to provide a semi-quantitative or quantitative assessment of receptor binding and cross-linking by the ligand.
FAQs
TGF-β first engages a receptor pair rather than acting through a single surface protein. Binding brings type II and type I serine/threonine kinase receptors into a signaling complex, allowing the receptor system to transmit the extracellular cue inward. This ordered receptor interaction initiates downstream SMAD phosphorylation and links ligand recognition to changes in gene regulation.
Phosphorylated SMAD proteins assemble into complexes that move into the nucleus. Once there, they influence gene transcription, converting receptor activation into altered cellular behavior. This nuclear step is important because it connects an event at the cell surface with changes in genes controlling processes such as growth, differentiation, tissue maintenance, and immune responses.
SMAD signaling provides a central route for transmitting TGF-β information, but it is not the only route. Additional non-SMAD pathways can also contribute to the cellular response, broadening how receptor activation is interpreted. Their contribution helps explain why TGF-β signaling can influence several biological outcomes rather than producing one uniform effect in every context.
The pathway regulates multiple cellular activities, including growth, differentiation, tissue maintenance, extracellular matrix production, and immune responses. Consequently, its effects depend on which biological process is being coordinated and whether signaling remains appropriately controlled. This breadth makes TGF-β important in normal biology while also creating multiple ways for abnormal activity to disturb tissue function.
Researchers can examine TGF-β activity in embryonic development, wound healing, extracellular matrix production, and immune regulation. These settings show how the pathway coordinates cells and tissues over time. Studying the same signaling system across these processes helps connect molecular events, such as receptor and SMAD activation, with broader outcomes in tissue formation, repair, maintenance, and defense.
Dysregulated TGF-β activity can disrupt the balance required for normal tissue maintenance and immune control. The overview identifies associations with fibrosis, inflammatory disease, and cancer, indicating that altered pathway activity may contribute to disease mechanisms in distinct ways. Comparing normal and abnormal signaling therefore helps investigators determine how regulatory failures relate to these conditions.
Because TGF-β signaling connects receptor activation with transcriptional changes and broad biological outcomes, it provides a framework for investigating disease mechanisms. Researchers can use this framework to examine how pathway activity changes in fibrosis, inflammatory disease, or cancer and to identify opportunities for targeted therapies. The goal is to relate pathway regulation to disease-specific biological consequences.